These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6621850)

  • 21. Hypothalamic functions, sleep and circadian rhythms in affective disorders.
    Mendlewicz J; Linkowski P
    Adv Biochem Psychopharmacol; 1987; 43():221-36. PubMed ID: 3035888
    [No Abstract]   [Full Text] [Related]  

  • 22. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor.
    Gold PW; Chrousos G; Kellner C; Post R; Roy A; Augerinos P; Schulte H; Oldfield E; Loriaux DL
    Am J Psychiatry; 1984 May; 141(5):619-27. PubMed ID: 6324597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of cimetidine on L-dopa-stimulated growth hormone release in normal man.
    Zanoboni A; Galmozzi G; Marinoni S; Zanoboni-Muciaccia W
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):535-40. PubMed ID: 6499233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seasonal independence of low prolactin concentration and high spontaneous eye blink rates in unipolar and bipolar II seasonal affective disorder.
    Depue RA; Arbisi P; Krauss S; Iacono WG; Leon A; Muir R; Allen J
    Arch Gen Psychiatry; 1990 Apr; 47(4):356-64. PubMed ID: 2322086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of L-dopa and GHRH on GH secretion in normal men.
    Alba-Roth J; von Creytz C; Mehltretter G; Schopohl J; Müller OA; von Werder K
    J Endocrinol Invest; 1989 Dec; 12(11):783-7. PubMed ID: 2515218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlations between the EEG pattern of sleep and depressive syndrome in patients with bipolar affective disorders before and during treatment with amitriptyline].
    Ekiert H; Gogol Z; Jernajczyk W
    Psychiatr Pol; 1983; 17(4):287-93. PubMed ID: 6657811
    [No Abstract]   [Full Text] [Related]  

  • 28. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human growth hormone response to levodopa. Relation to menopause, depression, and plasma dopa concentration.
    Sachar EJ; Altman N; Gruen PH; Glassman A; Halpern FS; Sassin J
    Arch Gen Psychiatry; 1975 Apr; 32(4):502-3. PubMed ID: 1119901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pooled prolactin measurements in the evaluation of short children.
    Shulman DI; Hu CS; Root AW; Bercu BB
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1261-7. PubMed ID: 2511222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
    J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine responses to levodopa in multiple system atrophy (MSA).
    Kimber J; Watson L; Mathias CJ
    Mov Disord; 1999 Nov; 14(6):981-7. PubMed ID: 10584673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypothalamic-pituitary evaluation in patients with galactorrhea-amenorrhea and hyperprolactinemia.
    Badawy SZ; Nusbaum ML; Omar M
    Obstet Gynecol; 1980 Jan; 55(1):1-7. PubMed ID: 6243406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of L-dopa and chlorpromazine on prolactin and growth hormone secretion in normal women.
    Leblanc H; Yen SS
    Am J Obstet Gynecol; 1976 Sep; 126(2):162-4. PubMed ID: 961756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depending on the stimulus, central serotoninergic activation by fenfluramine blocks or does not alter growth hormone secretion in man.
    Casanueva FF; Villanueva L; Peñalva A; Cabezas-Cerrato J
    Neuroendocrinology; 1984 Apr; 38(4):302-8. PubMed ID: 6374488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability of hormonal responses to a series of neuroendocrine challenges in depressed patients.
    Winokur A; Amsterdam J; Caroff S; Snyder PJ; Brunswick D
    Am J Psychiatry; 1982 Jan; 139(1):39-44. PubMed ID: 6798884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of amitriptyline on endocrine responses to intravenous L-tryptophan.
    Cowen PJ; McCance SL; Gelder MG; Grahame-Smith DG
    Psychiatry Res; 1990 Feb; 31(2):201-8. PubMed ID: 2326398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.
    Meltzer HY; Kolakowska T; Fang VS; Fogg L; Robertson A; Lewine R; Strahilevitz M; Busch D
    Arch Gen Psychiatry; 1984 May; 41(5):512-9. PubMed ID: 6721674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuroendocrinology of depressive disorders].
    Linkowski P; Mendlewicz J
    Sem Hop; 1982 Dec; 58(44):2589-95. PubMed ID: 6297052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.